Literature DB >> 23106315

Increased urinary aldosterone excretion is associated with subcutaneous not visceral, adipose tissue area in obese individuals: a possible manifestation of dysfunctional subcutaneous adipose tissue.

Eisaku Harada1, Yuji Mizuno, Daisuke Katoh, Yusuke Kashiwagi, Sumio Morita, Yoshiharu Nakayama, Michihiro Yoshimura, Hiroaki Masuzaki, Yoshihiko Saito, Hirofumi Yasue.   

Abstract

BACKGROUND: Aldosterone is reported to be associated with obesity and is a risk factor for metabolic syndrome. Metabolic abnormalities are more strongly associated with visceral adipose tissue (VAT) than with subcutaneous adipose tissue (SAT).
OBJECTIVE: We examined whether aldosterone is more closely associated with VAT area than with SAT area in obese individuals.
METHODS: We enrolled 81 Japanese patients (46 men, mean age 43 ± 13 years and 35 women, mean age 53 ± 10 years) suspected of metabolic disorders and measured plasma and 24-h urinary aldosterone, as well as SAT and VAT areas. SAT and VAT areas were measured at the umbilical level by computed tomography.
RESULTS: Spearman's rank correlation analysis showed that urinary aldosterone was significantly and positively correlated with body mass index, waist circumference, SAT area, alanine aminotransferase, C-reactive protein, plasma immune-reactive insulin, plasma renin activity and estimated glomerular filtration rate, and negatively correlated with age and blood glucose. Urinary aldosterone was not correlated with VAT area (r = 0·013, P = 0·906). Multivariate regression analyses revealed that log SAT area, age and diastolic blood pressure were significant (P = 0·001, 0·001 and 0·032, respectively) predictors of log urinary aldosterone excretion rate.
CONCLUSION: Our results indicate that urinary aldosterone excretion is positively associated with SAT but not with VAT area in the middle-aged obese individuals.Urinary aldosterone is also negatively correlated with age.
© 2012 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23106315     DOI: 10.1111/cen.12083

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  5 in total

Review 1.  Aldosterone Production and Signaling Dysregulation in Obesity.

Authors:  Andrea Vecchiola; Carlos F Lagos; Cristian A Carvajal; Rene Baudrand; Carlos E Fardella
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

Review 2.  Obesity and renovascular disease.

Authors:  Xin Zhang; Lilach O Lerman
Journal:  Am J Physiol Renal Physiol       Date:  2015-06-03

Review 3.  The regulation of aldosterone secretion by leptin: implications in obesity-related cardiovascular disease.

Authors:  Jessica L Faulkner; Thiago Bruder-Nascimento; Eric J Belin de Chantemèle
Journal:  Curr Opin Nephrol Hypertens       Date:  2018-03       Impact factor: 2.894

Review 4.  Genomic and rapid effects of aldosterone: what we know and do not know thus far.

Authors:  Milla Marques Hermidorff; Leonardo Vinícius Monteiro de Assis; Mauro César Isoldi
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

5.  Association of visceral adiposity and clinical outcome among patients with aldosterone producing adenoma.

Authors:  Leay Kiaw Er; Meng-Chun Lin; Yao-Chou Tsai; Jong-Kai Hsiao; Chung-Yi Yang; Chin-Chen Chang; Kang-Yung Peng; Jeff S Chueh; Vin-Cent Wu
Journal:  BMJ Open Diabetes Res Care       Date:  2020-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.